Osteoporosis

Med Clin North Am. 2023 Mar;107(2):213-225. doi: 10.1016/j.mcna.2022.10.013. Epub 2023 Jan 5.

Abstract

Osteoporosis is the most common bone disease in adults and confers significant morbidity and mortality in women. Universal screening is recommended for women above the age of 65 years; however, screening rates remain low. Bisphosphonates are the treatment of choice despite a decline in their use due to concerns about rare side effects. Treatment of osteoporosis dramatically decreases the likelihood of fragility fractures.

Keywords: Bisphosphonates; Bone density; Bone fracture; Falls; Hip fracture; Menopause; Osteopenia; Osteoporosis.

Publication types

  • Review

MeSH terms

  • Adult
  • Aged
  • Bone Density
  • Diphosphonates / adverse effects
  • Female
  • Fractures, Bone*
  • Humans
  • Osteoporosis* / diagnosis
  • Osteoporosis* / drug therapy

Substances

  • Diphosphonates